Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Hospital de Sabadell Bristol-Myers Squibb |
---|---|
Information provided by: | Hospital de Sabadell |
ClinicalTrials.gov Identifier: | NCT00144937 |
The purpose of this study was to evaluate whether an intensified multifactorial intervention program about cardiovascular risk factors in subjects with peripheral arterial disease (with and without diabetes mellitus), can improve the control of these factors (mainly hypercholesterolemia and hypertension) in relation to the habitual care
Condition | Intervention | Phase |
---|---|---|
Peripheral Arterial Disease Hypercholesterolemia Hypertension Diabetes Mellitus Smoking |
Drug: Stepwise therapy for dyslipidemia, hypertension and diabetes Behavioral: Dietary recommendations Behavioral: Increase in physical activity Behavioral: Smoking cessation |
Phase IV |
Study Type: | Interventional |
Study Design: | Educational/Counseling/Training, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | A Randomized Controlled Trial Comparing Usual Care With a Multifactorial Intensified Intervention on Cardiovascular Risk Factors in Subjects With Arterial Peripheral Disease With and Without Diabetes. The Taulí Intervention Program (TIP). |
Estimated Enrollment: | 120 |
Study Start Date: | March 2003 |
Estimated Study Completion Date: | August 2005 |
Subjects with peripheral arterial disease show an increased cardiovascular risk. It is thought that improving control of cardiovascular risk factors (hypercholesterolemia, hypertension, diabetes, smoking) could be beneficial in reducing their cardiovascular risk. However, usual care of these subjects (mainly at primary care) is not associated with an optimal control of such cardiovascular risk factors. We hypothesise that an intensive multifactorial treatment in a Cardiovascular Risk Unit could improve control of these cardiovascular risk factors. To test this hypothesis we perform a controlled, randomized, open, parallel trial. Subjects are recruited at the Vascular Surgery Unit and are randomised into two groups: 1. usual care (control group); 2. intensive care (intervention group). Randomization is stratified for the presence/absence of diabetes mellitus and with the use of sealed envelopes. Patients assigned to receive usual care (general practitioner with the possibility of being referred to specialists) are compared to those assigned to undergo intensive multifactorial intervention. This intervention involves strict treatment goals (LDL-cholesterol < 100 mg/dl, blood pressure < 130/80, HbA1c < 7 %, no smoking) to be achieved through behavior modification (diet, physical activity, smoking cessation) and a stepwise introduction of pharmacologic therapy for hypercholesterolemia, hypertension and diabetes. This multifactorial intervention is overseen by a multidisciplinary team (endocrinologist, nurse, and dietitian) at the Hospital of Sabadell (Corporación Parc Taulí). The treatment goals are the same for the usual care group and general practitioners caring patients included in this study are informed of these strict treatment goals. Patients in the intensive-therapy receive 6 scheduled individual consultations in one year (baseline and 2,4, 6 and 9 months after their inclusion).Primary and secondary outcomes are evaluated at 12 months after their inclusion.
Ages Eligible for Study: | 45 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Spain, Barcelona | |
Hospital de Sabadell | |
Sabadell, Barcelona, Spain, 08208 |
Principal Investigator: | José-Miguel González-Clemente, MD, PhD | Department of Diabetes, Endocrinology and Nutrition. Hospital de Sabadell |
Study Chair: | Dídac Mauricio, MD, PhD | Department of Diabetes, Endocrinology and Metabolism. Hospital de Sabadell |
Study ID Numbers: | 2003020 |
Study First Received: | September 1, 2005 |
Last Updated: | September 1, 2005 |
ClinicalTrials.gov Identifier: | NCT00144937 |
Health Authority: | Spain: Spanish Agency of Medicines |
Peripheral Vascular Diseases Metabolic Diseases Hyperlipidemias Diabetes Mellitus Vascular Diseases Endocrine System Diseases Smoking |
Endocrinopathy Glucose Metabolism Disorders Metabolic disorder Hypercholesterolemia Dyslipidemias Hypertension Lipid Metabolism Disorders |
Cardiovascular Diseases |